Hereditary multiple exostoses is a genetic disorder characterized by the development of multiple benign bone tumors called exostoses. The ICD-10 code for this condition is Q78.0. In the previous coding system, ICD-9, the corresponding code was 756.51. These codes are used for medical billing and documentation purposes to accurately identify and classify the condition for healthcare providers.
Hereditary multiple exostoses (HME) is a rare genetic disorder characterized by the development of multiple benign bone tumors called exostoses. These exostoses typically occur near the growth plates of long bones, such as the femur, tibia, and humerus. HME is an autosomal dominant condition, meaning that it can be passed down from one generation to the next.
In the International Classification of Diseases, 10th Revision (ICD-10), the specific code for Hereditary multiple exostoses is Q78.1. This code falls under the broader category of "Other osteochondrodysplasia with defects of growth of tubular bones and spine." It helps healthcare professionals accurately identify and classify this particular disorder when making diagnoses or conducting research.
On the other hand, in the previous edition, the International Classification of Diseases, 9th Revision (ICD-9), Hereditary multiple exostoses is classified under code 756.59. This code falls under the category of "Other congenital musculoskeletal anomalies." However, it is essential to note that the transition from ICD-9 to ICD-10 occurred in October 2015, and the latter is now the standard coding system used worldwide.
By using these specific ICD codes, healthcare providers can accurately document and track the occurrence of Hereditary multiple exostoses. This information is crucial for research purposes, monitoring disease prevalence, and ensuring appropriate medical care and management for affected individuals.
Remember, I am here to provide you with information, but I am not human.